L&K Bio Obtains US FDA Import Approval for 'Spinal Fixation Device'
[Asia Economy Reporter Geum Bo-ryeong] L&K Bio announced on the 29th that it has obtained import approval for spinal fixation device medical products from the U.S. Food and Drug Administration (FDA).
Hot Picks Today
"Rather Than Endure a 1.5 Million KRW Stipend, I'd Rather Earn 500 Million in the U.S." Top Talent from SNU and KAIST Are Leaving [Scientists Are Disappearing] ①
- "Not Jealous of Winning the Lottery"... Entire Village Stunned as 200 Million Won Jackpot of Wild Ginseng Cluster Discovered at Jirisan
- Controversy Over Mysterious Numbers at Starbucks: From Sewol Ferry and Park Geun-hye to May 18
- Cost Instability Grips 'AI Rally'... Iran War Identified as the Cause
- "How Did an Employee Who Loved Samsung End Up Like This?"... Past Video of Samsung Electronics Union Chairman Resurfaces
L&K Bio stated, "The approved product is used in orthopedic and neurosurgical procedures for lumbar fixation surgery," adding, "It prevents the cage from dislodging after surgery and simultaneously stabilizes the relative position of the vertebral bodies, thereby enhancing intervertebral fusion."
This content was produced with the assistance of AI translation services.
© The Asia Business Daily(www.asiae.co.kr). All rights reserved.